Scott Braunstein, SVP, Strategy & Corporate Development at Pacira Pharmaceuticals, Inc. (PCRX), bought 2,000 shares at $58.92 ($118K) on 2016-01-29, disclosed to the SEC on 2016-02-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| MRNS | SELL | 2024-02-21 | $118K | — | Filing → |
| MRNS | SELL | 2023-08-08 | $123K | — | Filing → |
| MRNS | BUY | 2019-12-13 | $125K | — | Filing → |